How will institutional review boards (IRBs) review study protocols involving the ever-increasing array of mobile health (mHealth) technologies and virtual trial apps on the market?
This webinar helps clinical research professionals to understand the regulations and how the oversight of virtual trials might differ from what they have traditionally been used to.
Upon completion of this continuing education program, participants should be able to:
Describe current regulations surrounding mHealth and virtual trial apps.
Identify potential IRB considerations for studies involving virtual trial technologies.
Outline ways researchers can prepare protocols with decentralized clinical trial technology for IRB review.
Speaker James Riddle, MCSE, CIP, CPIA, CRQM, Vice President, Research Services & Strategic Consulting, Advarra